SCHEMBL2848183

SCHEMBL2848183

NCC1(CN)COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1394599 0.97 EPHX1 (0.35)
SCHEMBL10626682 0.97
Hydrochloric Acid SCHEMBL7962177 0.97 EPHX1 (0.35)
Water SCHEMBL10625822 0.94 EPHX1 (0.33)
SCHEMBL10625735 0.88 EPHX1 (0.31)
SCHEMBL8904301 0.87
SCHEMBL10628691 0.84
SCHEMBL6124689 0.82
SCHEMBL1458569 0.82
SCHEMBL16259516 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0232784-B1 (GEM-HETEROCYCLODIMETHANAMINE-N,N')PLATINUM COMPLEXES AMERICAN CYANAMID COMPANY (US) 1992-12-02 EP claimed
EP-4739670-A1 MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2026-05-13 EP disclosed
US-20260125384-A1 INDAZOLE INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2026-05-07 US disclosed
WO-2026087442-A1 AMINO-IMIDAZOLE ANTIBACTERIAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2026-04-30 WO disclosed
WO-2025012057-A1 MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2025-01-16 WO disclosed
US-RE49481-E1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease HOFFMANN-LA ROCHE INC. (US) 2023-04-04 US disclosed
US-RE49481-E1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease HOFFMANN-LA ROCHE INC. (US) 2023-04-04 US disclosed
WO-2018050110-A1 NOVEL CAPSID PROTEIN ASSEMBLY INHIBITOR 正大天晴药业集团股份有限公司 2018-03-22 WO disclosed
EP-2766370-B1 COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE HOFFMANN LA ROCHE (CH) 2016-08-03 EP disclosed
EP-2766370-B1 COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE HOFFMANN LA ROCHE (CH) 2016-08-03 EP disclosed
US-5789617-A PROPELLANTS, EXPLOSIVES AND GASIFIERS AEROJET-GENERAL CORPORATION (US) 1998-08-04 US disclosed
US-5420311-A Explosices, propellants AEROJET GENERAL CORPORATION (US) 1995-05-30 US disclosed
WO-1994005643-A1 NEOPENTYL DIFLUOROAMINO COMPOUNDS FOR USE IN ENERGETIC FORMULATIONS AEROJET-GENERAL CORPORATION (US) 1994-03-17 WO disclosed
US-5272249-A Difluoroamino oxetanes and polymers formed therefrom for use in energetic formulations AEROJET-GENERAL CORPORATION (US) 1993-12-21 US disclosed
EP-0232784-B1 (GEM-HETEROCYCLODIMETHANAMINE-N,N')PLATINUM COMPLEXES AMERICAN CYANAMID COMPANY (US) 1992-12-02 EP disclosed
US-4880790-A ANTICANCER, ANTITUMOR AGENTS AMERICAN CYANAMID COMPANY (US) 1989-11-14 US disclosed
EP-0174542-B1 CIS-PLATINUM-COMPLEXES HAVING A PENTAERYTHRITOL DERIVATIVE AS LIGAND, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL AGENT CONTAINING THESE COMPOUNDS BEHRINGWERKE Aktiengesellschaft (DE) 1989-06-28 EP disclosed
US-4730069-A ANTITUMOR BEHRINGWERKE AKTIENGESELLSCHAFT (DE) 1988-03-08 US disclosed
EP-0232784-A2 (Gem-heterocyclodimethanamine-N,N')platinum complexes AMERICAN CYANAMID COMPANY (US) 1987-08-19 EP disclosed
EP-0174542-A2 Cis-Platinum-complexes having a pentaerythritol derivative as ligand, process for their preparation and pharmaceutical agent containing these compounds BEHRINGWERKE Aktiengesellschaft (DE) 1986-03-19 EP disclosed